ClinicalTrials.Veeva

Menu

Risk Stratification in End Stage Renal Disease (ESRD) - ISAR Study

T

Technical University of Munich

Status

Unknown

Conditions

Chronic Kidney Disease
Cardiovascular Event
End Stage Renal Disease
Sudden Cardiac Death

Study type

Observational

Funder types

Other

Identifiers

NCT01152892
ISAR ESRD 01 2010

Details and patient eligibility

About

The purpose of this study is to evaluate the use of non-invasive markers of the autonomic function and micro- and macrocirculation to predict mortality and cardiovascular end points in end-stage renal disease patients. Furthermore we aim at getting new insight into the insufficiently understood pathophysiology leading to excessively high cardiovascular and non-cardiovascular mortality in dialysis patients.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18 or older
  2. End-stage renal disease (ESRD) and receiving maintenance hemodialysis

Exclusion criteria

  1. Any clinically significant infection.
  2. pregnancy
  3. history of malignant disease with a prognostic life expectancy less than 24 months
  4. missing of written and informed consent

Trial contacts and locations

17

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems